Lightcalls.com
 

It doesn't matter whether you're re...

It doesn't matter whether you're religious or not--even atheists can benefit from the "fasting" regime followed in the hellenic Orthodox Church, according to a novel study.

Strict classic Orthodox Christians avoid specified meats three times a year: 40 days before Christmas, 48 days at Easter and 15 days in August for Assumption.

Each fast is associated with a different holiday. For example, at Christmas, the faithful are advised to avoid meat, encourages and dairy products, and eating fish is not allowed forward Wednesdays and Fridays.

Since all other fares are permitted, this is not a fast in the traditional thinking principle of avoiding all food. "The Orthodox Christians' diet, which is based in succession vegetables, legumes, fruit, cereals, bread and olive oil, is a Mediterranean-type diet with periodic abstinence from meat and other proceedss during the fasting periods," the consideration states, as published in the May 16 2003 issue of BMC Public Health, published from BioMedCentral.

University of Crete scientists discovered that those who followed the regimen to the literal sense had lower levels of total cholesterol and lower plains of the cholesterol-binding proteins called low-density lipoproteins (LDL) or "bad" cholesterol in their offspring after fasting.



Other Christians who did not tread close upon the fasting regimen did not exhibit this lowering of "bad" cholesterol Those who stuck to the temporary diet experienced no change in the vital fluid levels of high-density lipoprotein (HDL) or "good" cholesterol

There is a clear, known link between high horizontals of cholesterol and LDL in the offspring and heart disease, whereas HDL appears to be protective against heart disease. grecian Orthodox fasting reduced the plains of total cholesterol in the line by 9 percent and the of the same heights of LDL by 12 percent

While the of the same heights of HDL did not change significantly, the HDL/LDL ratio increased, which is considered healthy for the heart. Unfortunately, these of the same heights rose again after the nation who fasted resumed their normal diet--but not to the original on a levels This suggests that regular fasting may give any long-term protection against heart disease.

COPYRIGHT 2003 PRIMEDIA Intertec, a PRIMEDIA Company. All Rights Reserved

COPYRIGHT 2003 Gale Group



Other Articles
 -Morphotek will collaborat...
 -Eksigent Technologies nam...
 -The benefits of outsourci...
 -Sartorius Corporation ...
 -In our previous column, w...
 -Efoora appointed Michael ...
 -Affymax appointed Anne-Ma...
 -Traditionally, continuous...
 -New Brunswick Scientific ...
 -The German-American firm ...
 -Don G. Burstyn, formerly ...
 -American patients are mor...
 -Summary Prior to va...
 -BioPharm Editorial Adviso...
 -Australia agreed to spend...
 -The Biotechnology Industr...
 -Ambion, The RNA Company i...
 -Therapies based on living...
 -A recent survey found tha...
 -ViroLogic will acquire Ac...
 -Cardinal Health named Joh...
 -One of the greatest chall...
 -As the president of a sma...
 -Sweden-based Biovitrum wi...
 -Nanogen appointed David L...
 -The Experion Process Know...
 -Although biomedical resea...
 -The Supreme Court of Cana...
 -Netherlands-based DSM Bio...
 -David A. Smoller joined S...
 -A few months ago, I wrote...
 -Panacos Pharmaceuticals w...
 -Karen K. Vaccaro will res...
 -Acceleron Pharma appointe...
 -Two quarterly meetings of...
 -Illinois-based Abbot Labo...
 -FKI Logistics announced t...
 -The following corrections...
 -It its widest definition,...
 -UK-based Xcellsyz will li...
 -Andrew P. Aromando joined...
 -Invitrogen's comprehensiv...
 -Last month, we described ...
 -The Swiss life sciences c...
 -Protein Design Labs (PDL)...
 -Model It HNMR, the newest...
 -Tech transfer, like chang...
 -QLT and Atrix Laboratorie...
 -Dendreon announced Christ...
 -Baxter Pharmaceutical Sol...
 -The biopharmaceutical ind...
 -GlaxoSmithKline announced...
 -Montreal-based Caprion Ph...
 -Xenova Group recently ann...
 -Cole-Parmer's new 192-pag...
 -Over the last decade ther...
 -Benchmark your facility p...
 -As biotechnology organiza...
 -Frederick D. Sancillo, fo...
 -Insmed acquired a recombi...
 -Baxter Pharmaceutical Sol...
 -Model It HNMR, the newest...
 -DA's regulation 21 CFR Pa...
 -Robert P. Ryan joined Ath...
 -A new report from Busines...
 -Biotest offers a complete...
 -Swagelok offers a brochur...
 -Partnering is a global ph...
 -Human Genome Sciences CEO...
 -Shorten the process devel...
 -The licensure of biotechn...
 -Rodger Currie joined Amge...
 -The GEA Filtration Model ...
 -A multi-channel chemistry...
 -From June 6-9, San Franci...
 -Skanska USA Building Inc....
 -New Brunswick Scientific'...
 -AVI BioPharma appointed P...
 -Ambion, The RNA Company, ...
 -"If you want to be a...
 -Xcellerex appointed Susan...
 -Researchers identified th...
 -Cool Spring Business Park...
 -In October 2003, Shenzhen...
 -Laureate Pharma appointed...
 -After a 6-5 vote by Calif...
 -QSourcing, a service of Q...
 -The recent discovery of &...
 -Affymax added Douglas L. ...
 -USDA recently approved tw...
 -BioPharm International is...
 -Serologicals has released...
 -This document by Shenzhen...
 -Robert Bronstein joined A...
 -Gloucester Gains Fujisawa...
 -With more than 30 years o...
 -Pall's SUPRAdisc II depth...
 -In today's competitive ma...
 -Protein Design Labs repor...
 -Charles A. Rice will repl...
 -AstraZeneca's Faslodex (f...
.
© 2006 Lightcalls.com All rights reserved.